The mitochondrial biogenesis signaling pathway is a potential therapeutic target for myasthenia gravis via energy metabolism (Review)

Myasthenia gravis (MG) is an autoantibody-mediated autoimmune disease that is characterized by muscle weakness and fatigue. Traditional treatments for MG target the neuromuscular junction (NMJ) or the immune system. However, the efficacy of such treatments is limited, and novel therapeutic options f...

Descripción completa

Detalles Bibliográficos
Autores principales: Ke, Lingling, Li, Qing, Song, Jingwei, Jiao, Wei, Ji, Aidong, Chen, Tongkai, Pan, Huafeng, Song, Yafang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8120506/
https://www.ncbi.nlm.nih.gov/pubmed/34007311
http://dx.doi.org/10.3892/etm.2021.10134

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8120506/
https://www.ncbi.nlm.nih.gov/pubmed/34007311
http://dx.doi.org/10.3892/etm.2021.10134

Ejemplares similares